- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06529211
Effect of Ultrasound Cavitation Versus Whole Body Vibration on Abdominal Fat in Obese Adolescent Females
Effect of Ultrasound Cavitation Versus Whole Body Vibration on Abdominal Fat in Obese Adolescent Females: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Adolescence is a critical time associated with the development of obesity. About 80% of adolescents with obesity will continue to have this condition as an adult.
Obesity during adolescence is associated with a number of short- and long-term diseases including hypertension, diabetes mellitus type 2, hyperlipidemia, obstructive sleep apnea, psychological distress and future cardiovascular complications.
The investigators showed that there is an increasing demand for non-surgical procedures in the management of obesity that led to the development of non-invasive techniques for reducing localized subcutaneous adipose tissue.
One of these techniques is focused ultrasound cavitation. Research studies showed some benefits in the treatment of excess abdominal fat deposits with reduction in fat circumference without significant side effects.
Also, another non-invasive technique is whole body vibration (WBV). Some studies showed that when it is combined with dietary intervention leads to body weight reduction and improvement of overall body composition and fat reduction including abdominal fat
Both ultrasound cavitation (UC) and whole-body vibration (WBV) are non-invasive modalities with many positive effects on abdominal fat in obese adolescent females. The effect of both the UC and WBV has been separately investigated in previous studies. Though, no studies were found to compare the effect of both modalities in the management of abdominal fat in obese adolescent females. Therefore, this study will be conducted to explore the effect of UC versus WBV on abdominal fat in obese adolescent females.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christina yassa, Master
- Phone Number: +201228294939
- Email: christina.haram@gmail.com
Study Contact Backup
- Name: Peter Armanious
- Phone Number: +201017816200
- Email: peterfayek1985@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adolescent females suffer from abdominal obesity.
- Their ages will be ranged from 17 to 25 years old.
- Their body mass index (BMI) will be ranged from 30 to 35 kg/m2.
- Their waist circumference will be > 88 cm.
- Their WHR will be more than 0.88.
Exclusion Criteria:
Females will be excluded from the study if they have:
- Thyroid, hepatic and kidney disorders.
- Diabetes mellitus, coronary artery diseases, hypertension and congestive heart failure.
- Recent abdominal surgical scar or umbilical hernia.
- History of orthopedic implants insertion or cardiac pacemaker implantation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Low caloric diet group
low-caloric diet of 1500 kcal/day.
|
Low caloric diet: the participants will receive low caloric diet program (1500 Kcal/ day) for 6 weeks as follows: 45% carbohydrate, 20% fat and 35% proteins of total calorie intake.
|
|
Experimental: ultrasound cavitation group
The participants will be treated by ultrasound cavitation, in addition to the low-caloric diet of 1500 kcal/day.
|
Low caloric diet: the participants will receive low caloric diet program (1500 Kcal/ day) for 6 weeks as follows: 45% carbohydrate, 20% fat and 35% proteins of total calorie intake.
Ultrasound cavitation + Low caloric diet Low caloric diet program (1500 Kcal/ day): for 6 weeks. Ultrasound cavitation: It will be on abdomen for 30 minutes/session, 2 sessions/week for 6 weeks as follows:
|
|
Experimental: whole-body vibration group
The participants will be treated by whole body vibration, in addition to the low-caloric diet of 1500 kcal/day.
|
Low caloric diet: the participants will receive low caloric diet program (1500 Kcal/ day) for 6 weeks as follows: 45% carbohydrate, 20% fat and 35% proteins of total calorie intake.
Whole body vibration + Low caloric diet Low caloric diet program (1500 Kcal/ day) for 6 weeks. Whole body vibration: for 30 minutes/session, 2 sessions/week for 6 weeks as follows:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: Within 6 weeks
|
Within 6 weeks
|
|
|
BMI
Time Frame: Within 6 weeks
|
Weight/ height scale will be used to measure the weight and height of all females in all groups to calculate their BMI before and after treatment according to the following equation BMI = weight/ height² (kg/m²)
|
Within 6 weeks
|
|
Waist circumference
Time Frame: Within 6 weeks
|
It is a measurement taken around the waist at the level of the narrowest part of the torso, typically located between the bottom of the rib cage and the top of the hip bones (iliac crest).
It is used as an indicator of central obesity.
However, as a general guideline, a waist circumference of over 35 inches (88 cm) in women is often considered high and indicative of an increased health risk .
|
Within 6 weeks
|
|
Waist to hip ratio (WHR)
Time Frame: Within 6 weeks
|
Waist-to-hip ratio (WHR) is a measurement that compares the circumference of the waist to that of the hips.
The waist circumference is measured at the narrowest point of the torso, usually just above the belly button (umbilicus), and the hip circumference is measured at the widest part, 9 around the buttocks at level of greater trochanters; then dividing the waist circumference by the hip circumference.
The formula is as follows: WHR = Waist Circumference / Hip Circumference.
For women, a WHR above 0.85 is often considered high and indicative of an increased health risk.
|
Within 6 weeks
|
|
Abdominal skinfold thickness
Time Frame: Within 6 weeks
|
Abdominal skinfold thickness is a specific measurement used to estimate the amount of subcutaneous fat in that area.
It provides insights into the distribution of fat in the abdominal region.
The measurement is typically taken at a site approximately 2 cm to the right side of the belly button, and the skinfold is pinched with calipers to measure the thickness.
The measurement process involves firmly grasping the skin and underlying fat tissue with the calipers, ensuring that only the skin and fat are included in the measurement and not muscle or other tissues.
The measurement is recorded in millimeters (mm)
|
Within 6 weeks
|
|
Bioelectrical impedance analysis (BIA)
Time Frame: Within 6 weeks
|
In BIA, a small, safe electrical current is passed through the body using electrodes typically placed on the hands and feet.
The electrical current encounters resistance from tissues with lower water content, such as fat and bone, while it easily passes through tissues with higher water content, such as muscle.
By measuring the impedance (resistance and reactance) of the electrical current, BIA devices can estimate body composition parameters such as body fat percentage, lean body mass, and hydration levels.
BIA can provide a quick and non-invasive estimation of body composition.
Also, it is a useful tool for tracking changes in body composition over time and monitoring progress in fitness or weight loss programs.
|
Within 6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Azza Kassab, Cairo University
- Study Director: Manal El-Shafei, Cairo University
- Study Director: Mohamed AboEleinen, Cairo University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/004858
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Obesity
-
National Research Council, SpainMinisterio de Economía y Competitividad, SpainCompletedSubjects With Abdominal ObesitySpain
-
Ben-Gurion University of the NegevUniversity of Leipzig; Harvard School of Public Health (HSPH)CompletedMen With Mild Abdominal ObesityIsrael
-
Université Catholique de LouvainCompletedAbdominal ObesityBelgium
-
Pusan National University Yangsan HospitalCompletedAbdominal ObesityKorea, Republic of
-
KU LeuvenVLIR-UOS; Kyambogo University; Our Lady of Africa Mbuya Catholic ParishCompleted
-
Assiut UniversityUnknownAbdominal ObesityEgypt
-
University of LeipzigUnknown
-
Cairo UniversityCompleted
-
Dominion Aesthetic Technologies, Inc.Completed
-
University of TorontoCompletedAbdominal ObesityCanada
Clinical Trials on Low caloric diet
-
Cairo UniversityGhada ebrahim El Refaye - Department of Physical Therapy for Women's Health...Recruiting
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)CompletedMetabolic Syndrome | Abdominal ObesityUnited States
-
National Research Centre, EgyptWithdrawn
-
Cairo UniversityUnknownPolycystic Ovary Syndrome | Irregular MensesEgypt
-
Temple UniversityAlmond Board of CaliforniaCompletedHypertension | Obesity | Hyperlipidemia | Metabolic Syndrome XUnited States
-
Uppsala UniversityAstraZenecaUnknownWeight Loss | Bariatric Surgery Candidate | Type2 Diabetes | Insulin Sensitivity | Metabolism and Nutrition Disorder | Metabolism Disorder, GlucoseSweden
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 1 | Overweight and ObesityUnited States
-
Cantonal Hospital of St. GallenMedical University of Graz; European Foundation for the Study of DiabetesCompletedDiabetes Mellitus, Type 2 | Bariatric Surgery CandidateAustria, Switzerland
-
Cairo UniversityRecruitingObesity | Irritable Bowel Syndrome | Abdominal ObesityEgypt